Earnings Preview For RVL Pharmaceuticals
Portfolio Pulse from Benzinga Insights
RVL Pharmaceuticals (NASDAQ:RVLP) is set to release its latest quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $-0.13. The company's past performance shows a pattern of share price increases following earnings reports, despite EPS misses. The stock is currently trading at $0.4876, down 77.27% over the last 52-week period.
August 11, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
RVL Pharmaceuticals is expected to report an EPS of $-0.13. Despite past EPS misses, the company's share price has often increased post-report. However, the stock is down 77.27% over the last 52 weeks.
The upcoming earnings report is highly relevant to RVL Pharmaceuticals' stock. While the company has a history of EPS misses, its share price has often increased following the earnings report, suggesting that investors may be focusing more on the company's guidance than its earnings. However, the stock's significant decline over the past year indicates that there are other factors at play that could be negatively impacting the stock's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100